Global prevalence: Central nervous system tumors are a common type of tumor worldwide, occurring in both children and adults; prognosis varies significantly depending on the tumor type.
Staged treatment for central nervous system tumors
Early treatment (involving a localized, small tumor with a favorable response)
specifically surgical resection combined with adjuvant therapy—can effectively control tumor progression, and the patient's prognosis is relatively good.
Treatment for the intermediate stage (involving local spread; aiming to inhibit growth and delay progression)
employs a comprehensive approach—such as surgery combined with radiotherapy and chemotherapy—to control further tumor spread and slow the rate of disease deterioration.
Advanced-stage treatment (addressing severe involvement, alleviating symptoms, and prolonging survival)
primarily employs systemic therapies such as chemoradiotherapy and targeted therapy to alleviate clinical symptoms and maximize patient survival time.
Consequences of delayed early treatment: Failure to receive timely, standardized treatment in the early stages allows the tumor to continue growing and severely damaging nervous system function; missing the optimal window for intervention can be life-threatening.
Why choose Fosun Health for central nervous system tumor treatment
Central nervous system tumor diagnosis and treatment at Fosun Health are managed by a specialized neuro-oncology center; the team possesses extensive experience in microsurgery, stereotactic radiosurgery, and comprehensive postoperative chemoradiotherapy.Leveraging a global medical network, patients have access to cutting-edge international treatment options, including neuronavigation-assisted surgery, real-time intraoperative MRI monitoring, CyberKnife M6 stereotactic radiosurgery, proton beam therapy, and molecular targeted therapy.For complex cases, Multidisciplinary Team (MDT) consultations and cross-border consultation mechanisms facilitate second opinions from top-tier overseas medical centers.
Fosun Health possesses leading-edge technology in the treatment of central nervous system tumors.The MR-guided focused ultrasound brain treatment system (MR-guided FUS/Exablate), introduced by Fosun Pharma, has successfully treated over 25,000 patients worldwide, offering a new non-invasive treatment option for deep-seated brain tumors.Foshan Fosun Chancheng Hospital is equipped with the sixth-generation CyberKnife M6 system, achieving stereotactic radiosurgery precision at the 0.1-millimeter level.The world's first 128-channel, helium-free Marvel MEG (magnetoencephalography) system delivers an integrated solution—spanning from precise localization to non-invasive treatment—significantly enhancing the standard of care for brain tumors.
Treatment methods for CNS tumors
1.CyberKnife precision radiotherapy
CyberKnife precision radiotherapy may be considered based on lesion location and treatment history for certain small, relatively well-defined central nervous system tumors that are suitable for stereotactic radiotherapy.
Treatment advantages:
① Precise focusing: Using image guidance to concentrate a high dose on the target lesion.
② Non-craniotomy treatment: Does not require traditional craniotomy.
③ Applicable to specific lesions: Can be used for select small-volume tumors, as well as postoperative residual or locally recurrent lesions.
④ Protection of normal tissue: Minimize radiation exposure to surrounding normal brain tissue and critical neural structures through dose optimization.
2.VitalBeam linear accelerator precision radiotherapy
For selected patients with malignant central nervous system tumors, as well as those with postoperative residual or recurrent lesions, precision radiotherapy may be selected based on tumor type, extent, and the status of surrounding critical structures.
Treatment advantages:
① Precise radiotherapy: Formulate an individualized plan based on the location, size, and pathological type of the lesion.
② Dose optimization: Improves target area coverage and minimizes radiation exposure to normal brain tissue.
③ Flexible fractionation: Single-fraction or fractionated radiotherapy can be selected based on the size of the lesion and surrounding vital structures.
④ Postoperative adjuvant therapy: Can be used in combination with surgery, depending on pathology and the status of residual lesions.
3. Microsurgical tumor resection
For localized central nervous system tumors with clear surgical indications and locations suitable for surgery, microsurgical resection may be evaluated based on lesion location, size, and its relationship with critical neural structures.
4.Whole-brain radiotherapy
For selected patients with multiple brain metastases, diffuse intracranial lesions, or conditions unsuitable for local stereotactic radiotherapy, whole-brain radiotherapy may be evaluated based on lesion distribution, prognosis, and prior treatment history.
Treatment advantages:
① Broad coverage: Capable of covering known and potential micrometastases throughout the brain.
② Suitable for multiple lesions: Offers therapeutic value for certain cases of multiple intracranial metastatic lesions.
③ Combined local therapy: Can be combined with surgery or stereotactic radiotherapy depending on the distribution of lesions.
④ Personalized selection: Evaluate treatment methods by considering the patient's neurological function, systemic disease status, and prognosis.
5.Interventional therapy
For certain central nervous system tumors that are highly vascular or present clear indications for vascular intervention, treatments such as endovascular embolization may be evaluated based on tumor type, location, and blood supply; in some cases, this may serve as an adjuvant therapy prior to surgery.
6.Chemotherapy
Uses anticancer drugs such as temozolomide to kill cancer cells and effectively control the rate of tumor progression; commonly used for patients with malignant brain tumors.
7.Targeted therapy
Precision targeting of specific molecular markers offers favorable efficacy and relatively mild side effects, making it suitable for select patients with recurrent tumors.
8.Immunotherapy
Activates the body's immune system to recognize and attack cancer cells, offering a new treatment option for patients with advanced central nervous system tumors.
9.Proton beam therapy
Uses proton beams to precisely target tumor tissue while maximizing protection of surrounding normal nerve tissue; suitable for tumors in challenging locations.
10 Comprehensive treatment
Formulate an individualized comprehensive treatment plan—combining surgery, chemoradiotherapy, and other modalities based on the patient's specific condition—to enhance therapeutic efficacy.
11 Supportive care
Approaches such as nutritional support, psychological counseling, and rehabilitation training can comprehensively improve the patient's physical condition and quality of life.
Post-treatment care
Maintain a regular daily routine and a balanced diet; avoid strenuous exercise; attend scheduled follow-up appointments and actively cooperate with rehabilitation treatment as advised.
Post-treatment examinations
Periodic cranial or spinal cord MRI, neurological function assessments, and follow-up imaging are required after treatment to timely detect changes in the disease status.
Conclusion
Central nervous system tumors pose a serious health threat; successful treatment relies on early detection, diagnosis, and intervention, as well as the selection of appropriate treatment plans and consistent follow-up to prolong survival.
